NUS Net Invested Capital from 2010 to 2024
NUS Stock | USD 12.01 0.04 0.33% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 1.3 B | Current Value 1.4 B | Quarterly Volatility 103 M |
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NUS main balance sheet or income statement drivers, such as Depreciation And Amortization of 49.6 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many exotic indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0842 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
NUS | Net Invested Capital |
Latest Nu Skin's Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of Nu Skin Enterprises over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Nu Skin's Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
Timeline |
NUS Net Invested Capital Regression Statistics
Arithmetic Mean | 1,180,257,593 | |
Geometric Mean | 1,176,165,513 | |
Coefficient Of Variation | 8.73 | |
Mean Deviation | 92,833,700 | |
Median | 1,093,226,000 | |
Standard Deviation | 102,994,394 | |
Sample Variance | 10607.8T | |
Range | 271.8M | |
R-Value | 0.92 | |
Mean Square Error | 1777.8T | |
R-Squared | 0.84 | |
Slope | 21,162,451 | |
Total Sum of Squares | 148509.8T |
NUS Net Invested Capital History
About Nu Skin Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Nu Skin income statement, its balance sheet, and the statement of cash flows. Nu Skin investors use historical funamental indicators, such as Nu Skin's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may use each financial statement separately, they are all related. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nu Skin's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Nu Skin Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Nu Skin. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Invested Capital | 1.3 B | 1.4 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Nu Skin Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for NUS Stock analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 1.56 | Earnings Share 0.17 | Revenue Per Share 39.612 | Quarterly Revenue Growth (0.07) |
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.